Literature DB >> 16352636

Shortening infusion times for infliximab administration.

M H Buch, D Bryer, S Lindsay, B Rees-Evans, A Fairclough, P Emery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16352636     DOI： 10.1093/rheumatology/kei247

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

1.  DEHP Nanodroplets Leached From Polyvinyl Chloride IV Bags Promote Aggregation of IVIG and Activate Complement in Human Serum.

Authors:  Jared R Snell; Connor R Monticello; Cheng Her; Emma L Ross; Ashley A Frazer-Abel; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2019-06-21       Impact factor: 3.534

2.  A quality improvement project reduces time spent at an inflammatory bowel disease infusion center with accelerated infliximab infusion protocol.

Authors:  Wan Chee Ong; Miao Shan Lim; Elaine Chan; Thomson Chong Teik Lim; Teong Guan Lim; Webber Chan
Journal:  JGH Open       Date:  2022-06-01

3.  The Tolerability and Efficacy of Rapid Infliximab Infusions in Patients with Inflammatory Bowel Disease.

Authors:  Taha Qazi; Bhavesh Shah; Mohammed El-Dib; Francis A Farraye
Journal:  Dig Dis Sci       Date:  2015-10-06       Impact factor: 3.199

4.  Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter study.

Authors:  Anna Viola; Giuseppe Costantino; Antonino Carlo Privitera; Fabrizio Bossa; Angelo Lauria; Laurino Grossi; Maria Beatrice Principi; Nicola Della Valle; Maria Cappello
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-05-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.